Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Journal of Biomedical Science|May 9, 2022
Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancerJai-Shin Liu, Wei-Kai Fang, Shan-Min Yang, et al.
Neoplasia (New York, N.Y.)|November 14, 2025
Oral bioavailable ITRI-148 degrades androgen receptor variants and overcomes antiandrogen resistance in advanced prostate cancerChiu-Lien Hung, Wen-Ning Hsu, Tsan-Chun Wang, et al.
Oncogene|August 4, 2018
KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPCHung-Jung Wang, Mamata Pochampalli, Ling-Yu Wang, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2024
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivirWen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2025
Targeting SARS-CoV-2 RNA-dependent RNA polymerase with the coumarin derivative BPR2-D2: Evidence from cell-based and enzymatic studiesWen-Fang Tang, Hui-Ping Tsai, Yuan-Fan Chin, et al.
Pageof 6